Results 231 to 240 of about 605,792 (294)

Corrigendum: Estrogens modulate somatostatin receptors expression and synergize with the somatostatin analog pasireotide in prostate cells

open access: yesFrontiers in Pharmacology
Valentina Rossi   +8 more
doaj   +1 more source

Powerful Inhibition of Experimental Human Pancreatic Cancers by Receptor Targeted Cytotoxic LH-RH analog AEZS-108 [PDF]

open access: yes, 2017
Abi-Chaker, Andrew   +8 more
core  

Osteoporosis and fragility fractures in patients with acromegaly: A two-center cross-sectional study. [PDF]

open access: yesWorld J Orthop
Alvarez M   +7 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Somatostatin and its Analogs

Current Drug Targets, 2016
Somatostatin (SST) is a cyclic hormone-release inhibitory peptide that has high binding affinity to all of its five SST receptors (SSTRs). SST negatively regulates cell proliferation and the release of multiple hormones via activation of its cognate receptors.
Lichun, Sun, David H, Coy
openaire   +3 more sources

Somatostatin, Somatostatin Analogs and Somatostatin Receptor Dynamics in the Biology of Cancer Progression

Current Molecular Medicine, 2013
The pharmacological effects (i.e., inhibition of endocrine secretion and cell proliferation) mediated by the hormone somatostatin (SRIF) are derived from its universal high-affinity binding to five different G proteincoupled receptors (GPCRs), named sst1-5.
Ruscica M   +4 more
openaire   +5 more sources

Somatostatin analogs

The Journal of Peptide Research, 2001
Abstract:  Somatostatin is a hypothalamic peptide hormone that inhibits the secretion of growth hormone, glucagon, insulin, gastrin and secretin, and also plays a role in neural transmission. Because of its wide range of possible clinical applications hundreds of somatostatin analogs have been synthesized and bioassayed to date.
A, Janecka, M, Zubrzycka, T, Janecki
openaire   +2 more sources

Home - About - Disclaimer - Privacy